The CXCL12/CXCR4/ACKR3 Response Axis in Chronic Neurodegenerative Disorders of the Central Nervous System: Therapeutic Target and Biomarker.
Cell Mol Neurobiol
; 42(7): 2147-2156, 2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-34117967
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Chemokine CXCL12
/
Receptors, CXCR
Limits:
Aged
/
Humans
Language:
En
Journal:
Cell Mol Neurobiol
Year:
2022
Document type:
Article
Country of publication: